Kogulugu

Act Amending the Health Insurance Act and Other Acts (Reform of Assistive Devices and Medical Devices) ↗

Introduced:
29 September 2026
Author:
Government (Ministry of Social Affairs) · coalition at introduction: Reform, Eesti 200
Stage
Second reading

The draft merges the funding of assistive devices (now via the Social Insurance Board) and medical devices into one Health Insurance Fund (Tervisekassa) system. Assistive devices move over in three stages in 2027–2029. It also changes medical device price rules and who may issue a device card, and simplifies medical device requirements. It enters into force on 1. jaanuaril 2027.

Changes and additions

  1. Transfer of assistive devices to Tervisekassa

    Assistive devices are funded by the Social Insurance Board (Sotsiaalkindlustusamet, SKA) under the social welfare act, and medical devices by Tervisekassa, in parallel systems.
    Assistive devices move in three stages (2027, 2028, 2029) into Tervisekassa's medical devices list. By early 2029 one product-based list remains. Guide dogs stay with SKA for now.
  2. Definition of medical device and rental

    The definition in the Health Insurance Act (Ravikindlustuse seadus, RaKS) largely duplicates the EU regulations and ties devices to treating illness or injury. Devices compensating impaired function were left to SKA's funding.
    The definition refers to the EU regulations and covers all products SKA reimburses (e.g. shoes, prostheses, wheelchairs). A legal basis is created to reimburse rental too.
  3. Price agreements and retail price limit

    New RaKS § 48² sets out how price agreements are concluded and changed. All sellers and lessors, pharmacies included, must keep retail prices at or below the agreed price when selling with Tervisekassa's subsidy.
  4. Reference price and reimbursement rate

    Two similar but different 'piirhind' (reference price) concepts were in use, and the rules on reference price and rate were less clear.
    Agreed price, reference price, retail price and reference-price group are defined. The reference price is the unit price of the second-cheapest comparable device. If the retail price is lower, the 90% or 50% rate applies to it. For people up to 18 the rate stays 90%.
  5. Who may issue a medical device card

    Only a doctor may issue a medical device card.
    Other specialists (e.g. nurses, midwives, physiotherapists, occupational therapists) may issue cards. Tervisekassa's list sets which specialist may issue a card for each device group.
  6. Resident doctors' prescribing right

    A resident's right to prescribe is limited by the year of residency. A supervising specialist must draw up or confirm the prescription.
    A resident may prescribe medicines from the first year of residency, on equal terms with a doctor who has completed the specialty. The right applies only within residency.
  7. Tax debt as ground to refuse a contract

    Tervisekassa may refuse to conclude a contract with a seller or lessor that has a tax debt.
  8. Medical device rule simplifications

    Lower-risk clinical studies (MDR art 82) need a permit. Every distributor must notify the Medicines Agency (Ravimiamet). The notice period for custom-made devices is 10 days.
    Lower-risk studies need only a notification to Ravimiamet. Only those who bring a device into the Estonian market notify distribution. The notice for custom-made devices is 30 days. Data is kept 30 years and logs 3 years.

Votes

No votes have been held yet.

Sources (Riigikogu documents) (7)

Official page of the bill on the Riigikogu website: proceedings and all documents.